Mary E Kelley1, Claire Ramsay Wan2, Beth Broussard3, Anthony Crisafio4, Sarah Cristofaro5, Stephanie Johnson5, Thomas A Reed4, Patrick Amar5, Nadine J Kaslow5, Elaine F Walker6, Michael T Compton7. 1. Rollins School of Public Health of Emory University, Department of Biostatistics and Bioinformatics, Atlanta, GA, United States. 2. Tufts University School of Medicine, Physician Assistant Program, Boston, MA, United States. 3. Lenox Hill Hospital, Department of Psychiatry, New York, NY, United States. 4. The George Washington University School of Medicine and Health Sciences, Washington, DC, United States. 5. Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta, GA, United States. 6. Emory University College of Arts and Sciences, Department of Psychology, Atlanta, GA, United States. 7. Lenox Hill Hospital, Department of Psychiatry, New York, NY, United States; Hofstra Northwell School of Medicine, Hempstead, NY, United States. Electronic address: mcompton@northwell.edu.
Abstract
OBJECTIVES: Several studies suggest that adolescent marijuana use predicts earlier age at onset of schizophrenia, which is a crucial prognostic indicator. Yet, many investigations have not adequately established a clear temporal relationship between the use and onset. METHODS: We enrolled 247 first-episode psychosis patients from six psychiatric units and collected data on lifetime marijuana/alcohol/tobacco use, and ages at onset of prodrome and psychosis in 210 of these patients. Cox regression (survival analysis) was employed to quantify hazard ratios (HRs) for effects of diverse premorbid use variables on psychosis onset. RESULTS: Escalation of premorbid use in the 5years prior to onset was highly predictive of an increased risk for onset (e.g., increasing from no use to daily use, HR=3.6, p<0.0005). Through the analysis of time-specific measures, we determined that daily use approximately doubled the rate of onset (HR=2.2, p<0.0005), even after controlling for simultaneous alcohol/tobacco use. Building on previous studies, we were able to determine that cumulative marijuana exposure was associated with an increased rate of onset of psychosis (p=0.007), independent of gender and family history, and this is possibly the reason for age at initiation of marijuana use also being associated with rate of onset in this cohort. CONCLUSIONS: These data provide evidence of a clear temporal relationship between escalations in use in the five years pre-onset and an increased rate of onset, demonstrate that the strength of the association is similar pre- and post-onset of prodromal symptoms, and determine that early adult use may be just as important as adolescent use in these associations.
OBJECTIVES: Several studies suggest that adolescent marijuana use predicts earlier age at onset of schizophrenia, which is a crucial prognostic indicator. Yet, many investigations have not adequately established a clear temporal relationship between the use and onset. METHODS: We enrolled 247 first-episode psychosispatients from six psychiatric units and collected data on lifetime marijuana/alcohol/tobacco use, and ages at onset of prodrome and psychosis in 210 of these patients. Cox regression (survival analysis) was employed to quantify hazard ratios (HRs) for effects of diverse premorbid use variables on psychosis onset. RESULTS: Escalation of premorbid use in the 5years prior to onset was highly predictive of an increased risk for onset (e.g., increasing from no use to daily use, HR=3.6, p<0.0005). Through the analysis of time-specific measures, we determined that daily use approximately doubled the rate of onset (HR=2.2, p<0.0005), even after controlling for simultaneous alcohol/tobacco use. Building on previous studies, we were able to determine that cumulative marijuana exposure was associated with an increased rate of onset of psychosis (p=0.007), independent of gender and family history, and this is possibly the reason for age at initiation of marijuana use also being associated with rate of onset in this cohort. CONCLUSIONS: These data provide evidence of a clear temporal relationship between escalations in use in the five years pre-onset and an increased rate of onset, demonstrate that the strength of the association is similar pre- and post-onset of prodromal symptoms, and determine that early adult use may be just as important as adolescent use in these associations.
Authors: Michael T Compton; Victoria H Chien; Amy S Leiner; Sandra M Goulding; Paul S Weiss Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2008-07-05 Impact factor: 4.328
Authors: Michael T Compton; Tynessa L Gordon; Sandra M Goulding; Michelle L Esterberg; Tandrea Carter; Amy S Leiner; Paul S Weiss; Benjamin G Druss; Elaine F Walker; Nadine J Kaslow Journal: J Clin Psychiatry Date: 2011-02 Impact factor: 4.384
Authors: Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis Journal: Lancet Date: 2007-07-28 Impact factor: 79.321
Authors: Marta Di Forti; Hannah Sallis; Fabio Allegri; Antonella Trotta; Laura Ferraro; Simona A Stilo; Arianna Marconi; Caterina La Cascia; Tiago Reis Marques; Carmine Pariante; Paola Dazzan; Valeria Mondelli; Alessandra Paparelli; Anna Kolliakou; Diana Prata; Fiona Gaughran; Anthony S David; Craig Morgan; Daniel Stahl; Mizanur Khondoker; James H MacCabe; Robin M Murray Journal: Schizophr Bull Date: 2013-12-17 Impact factor: 9.306
Authors: Luca Pauselli; Michael L Birnbaum; Beatriz Paulina Vázquez Jaime; Enrico Paolini; Mary E Kelley; Beth Broussard; Michael T Compton Journal: Schizophr Res Date: 2018-02-04 Impact factor: 4.939
Authors: Jacob Cookey; Jacob McGavin; Candice E Crocker; Kara Matheson; Sherry H Stewart; Philip G Tibbo Journal: Can J Psychiatry Date: 2020-02-04 Impact factor: 4.356
Authors: Michael L Birnbaum; Sean D Cleary; Claire Ramsay Wan; Luca Pauselli; Michael T Compton Journal: Early Interv Psychiatry Date: 2017-10-20 Impact factor: 2.732
Authors: Rohit J Lodhi; Yabing Wang; David Rossolatos; Georgina MacIntyre; Alexandra Bowker; Candice Crocker; Hongyan Ren; Aleksandra Dimitrijevic; Darren A Bugbee; Alexandra Loverock; Brett Majeau; Sudhakar Sivapalan; Virginia M Newton; Philip Tibbo; Scot E Purdon; Katherine J Aitchison Journal: Brain Behav Date: 2017-10-06 Impact factor: 2.708